At home in different industrial fields

The core competences of BCNP Consultants are the industrial fields of biotech, chemistry, nanotech and pharma as well as user industries such as medical technology and energy.

Due to the interdisciplinary character of natural sciences, technology and healthcare, BCNP Consultants GmbH is also actively involved in closely related industry segments such as medical technology. The central precondition for our consulting services is our ability to provide our clients with experience, industry knowledge and network contacts in order to create solutions.

Biotech

No other industry in the Life Sciences has attracted so much interest; in no other industry people put so many hopes. In the end, scientific developments often take longer than expected, especially in finding and developing drugs.

We support our clients in plotting the course by assessing markets for news products and by managing complex projects.

Chemistry

The importance of this industry for the creation of worldwide prosperity is often underestimated. However, no other industry is creating so many basic innovations and is actively engaged in sustainable production as a starting point for many user industries such as automotive, computer, health, energy and communication.

We support our clients in technology assessments, feasibility studies and getting in contact with innovative companies from the founder's scene.

Nanotech

Already today, a lot of products contain nanofillers or materials have nanostructured surfaces. Young companies using innovative methods for the production or the processing of nanoparticles are as active as the great chemical giants: a promising sector par excellance.

We support our clients in keeping ahead in this booming industry by competitor analyses, market research and by consulting in legal matters (REACH).

Pharma

The pharmaceutical industry is a central pillar of the health market in which besides classical drugs bio-pharmaceuticals are of increasing importance. The next step to the production of biosimilars (biogenerics) has already been undertaken. A lot of companies are diversifying and new market players from other industries are trying to enter the health industry.

We support our clients in assessing markets; we provide them with qualified contacts to cooperation partners and help to choose the right innovations for licensing.